Greg Hunter

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced its third quarter financial results Thursday for the three months ended Sept. 30, 2024. Q3 Financial Highlights Net revenue totaled CA$9.8 million ($7 million), representing a 15% increase year-over...

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of around C$1 million sequentially but an increase of C$1.3 million over the year. CEO David Pidduck...

Cannabinoid-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced Monday its financial results for the three months ended June 30, 2023, revealing revenue of CA$9.58 million ($7.11 million) compared to CA$4.36 million in the same period last...

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced financial results for Q1 2023, revealing EBITDA growth over the past two years and a significant reduction in losses to CA$2.1 million. Q1 2023 Highlights Adjusted EBITDA of $2.31 million (CA $3.1 million) with the inclusion...

MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1.8% compared to CA$21.7 million in FY 2021. FY 2022 Financial Highlights Gross loss of CA$1.9 million compared to gross loss of CA$15.4 million in FY 2021. Net loss of...

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) revenue decreased 11.24% to $4.88 million in Q1 2022 compared to $5.5 million in Q1 2021. Q1 Financial Highlights Gross profit was a loss of $403,000 compared to a loss of $680,000 in 2021 Net loss was $7.46 million, compared to a net...

MediPharm Labs Corp. (OTC: MEDIF) a pharmaceutical company specializing in precision-based cannabinoids, announced on Thursday its financial results for the Fourth Quarter and Full-Year that ended on December 31, 2021. 2021 Highlights  International sales more than doubled in 2021, to $9.5...